Actionnariat et activité des initiés pour Sana Biotechnology, Inc. (SANA): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $2.92 |
| Capitalisation | $813M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-26 | PATEL DHAVALKUMAR DHIRAJLAL | M-Exempt | 125,000 | |
| 2026-08-26 | PATEL DHAVALKUMAR DHIRAJLAL | M-Exempt | 125,000 | |
| 2026-08-27 | PATEL DHAVALKUMAR DHIRAJLAL | F-InKind | 41,158 | $169K |
| 2026-07-06 | Bishop Hans Edgar | A-Award | 6,297 | |
| 2026-06-04 | Yang Patrick Y | A-Award | 90,000 | $266K |
| 2026-06-04 | Rosiello Robert L. | A-Award | 90,000 | $266K |
| 2026-06-04 | Seitz Michelle | A-Award | 90,000 | $266K |
| 2026-06-04 | REICIN ALISE | A-Award | 90,000 | $266K |
| 2026-06-04 | Mulligan Richard | A-Award | 90,000 | $266K |
| 2026-06-04 | Bishop Hans Edgar | A-Award | 90,000 | $266K |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $30.6M | $80.0M | $124.8M | $253.0M | $176.8M | $133.5M | $127.6M | $71.9M |
| Placements à Court Terme | 0 | $59.0M | $253.5M | $298.0M | $247.2M | $71.7M | $24.9M | $66.5M |
| Créances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stocks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $32.6M | $144.3M | $384.5M | $558.1M | $444.4M | $213.5M | $160.8M | $148.7M |
| Immobilisations Corporelles | $585000 | $68.8M | $109.9M | $161.8M | $159.4M | $145.6M | $135.3M | $65.2M |
| Goodwill | 0 | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M | $140.6M |
| Actifs Incorporels | 0 | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M | $59.2M |
| Actifs Totaux | $34.3M | $415.2M | $730.3M | $1.13B | $822.7M | $565.3M | $501.0M | $416.9M |
| Dettes Fournisseurs | $289000 | 0 | $2.3M | $2.2M | $2.9M | $4.1M | $5.2M | $1.7M |
| Dette à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $1.8M | $19.3M | $31.5M | $99.2M | $111.5M | $64.5M | $45.4M | $78.7M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $47.5M | $557.7M | $1.15B | $400.9M | $323.4M | $277.8M | $250.5M | $256.0M |
| Réserves | -$13.2M | -$144.1M | -$429.4M | -$785.4M | -$1.05B | -$1.34B | -$1.60B | -$1.85B |
| Capitaux Propres | -$13.2M | -$142.5M | -$421.2M | $728.5M | $499.3M | $287.5M | $250.5M | $160.9M |
| Dette Totale | 0 | $47.7M | $71.9M | $110.9M | $108.3M | $104.1M | $94.2M | $78.9M |
| Dette Nette | -$30.6M | -$91.3M | -$306.4M | -$440.1M | -$315.7M | -$101.1M | -$58.3M | -$59.5M |
| Fonds de Roulement | $30.8M | $124.9M | $353.0M | $458.9M | $332.9M | $149.0M | $115.4M | $70.0M |
Santé financière
| Dette / Capitaux propres | 0.48 |
| Ratio de liquidité | 1.38 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -5.10 |
Rentabilité
| Rentabilité des capitaux propres | -134.49% |
| Rentabilité du capital investi | -64.54% |
| Rentabilité des actifs | -49.09% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: DNTH · INBX · KOD · NKTR · NRIX · OCS · PHAT
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de SANA: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions